BCM
EMN icon

BlueCrest Capital Management’s Eastman Chemical EMN Stock Holding History

BlueCrest Capital Management’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-40,000
Closed -$3.03M – 650
2014
Q4 		$3.03M Buy
+40,000
New +$3.16M 0.1% 208

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlueCrest Capital Management's EMN Position: Q2 2019 in Review

BlueCrest Capital Management sold out of Eastman Chemical (EMN) in Q2 2019, closing a stake of 8,166 shares — an estimated $620K sold.

BlueCrest Capital Management first reported a position in EMN in Q4 2014 and held it in 12 quarters. The position peaked at $15M in Q4 2017. 636 funds tracked by Wall St. Rank hold EMN as of Q2 2019.

  • BlueCrest Capital Management reported no remaining Eastman Chemical position as of Q2 2019 after selling out during the quarter.
  • BlueCrest Capital Management sold 8,166 Eastman Chemical shares in Q2 2019, an estimated $620K.
  • BlueCrest Capital Management first reported a position in Eastman Chemical in Q4 2014 and held it in 12 quarters.
  • BlueCrest Capital Management's Eastman Chemical position peaked at $15M in Q4 2017.
  • 636 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2019.

Based on BlueCrest Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.